Following i.t. DMXAA, both control and CCR2 KO mice showed reduction in UPS tumor volumes (Figures 7E), tumor bioluminescence (Figure 7F), and tumor free survival 90-days post-UPS engraftment (Figure 7G). The gene discussed is CCR2; the disease is undifferentiated pleomorphic sarcoma.